Product
Homepage
/
/
Active pharmaceutical ingredients
/
Intermediate
/
(R)-(4-Fluorophenyl)oxirane

Intermediates

(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol
(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol
(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethanol
More 白箭头 黑箭头
(1S,2S,3R,5S)-(+)-2,3-Pinanediol
(1S,2S,3R,5S)-(+)-2,3-Pinanediol
(1S,2S,3R,5S)-(+)-2,3-Pinanediol
More 白箭头 黑箭头
(2R, 3S)-2-[(1R)-l-[3, 5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine,4-methylbenzenesulfonate
(2R, 3S)-2-[(1R)-l-[3, 5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine,4-methylbenzenesulfonate
(2R, 3S)-2-[(1R)-l-[3, 5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholine,4-methylbenzenesulfonate
More 白箭头 黑箭头
(2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol
(2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol
(2R,3R)-2-(2,4-Difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butane-2,3-diol
More 白箭头 黑箭头
(R)-(+)-1-(1-Naphthyl)ethanol
(R)-(+)-1-(1-Naphthyl)ethanol
(R)-(+)-1-(1-Naphthyl)ethanol
More 白箭头 黑箭头
(R)-(+)-1-(1-Naphthyl)ethylamine
(R)-(+)-1-(1-Naphthyl)ethylamine
(R)-(+)-1-(1-Naphthyl)ethylamine
More 白箭头 黑箭头
(R)-(+)-1-Phenylethanol
(R)-(+)-1-Phenylethanol
(R)-(+)-1-Phenylethanol
【Alias】L-Phenylethanol; (R)-(+)-1-Phenylyl alcohol; R-(+)-sec-phenylethanol
【Catalog Number】CR8011
【CAS #】1517-69-7
【Molecular Formula】 C8H10O
【Molecular Weight】122.16
More 白箭头 黑箭头
(R)-(3-Chlorophenyl)oxirane
(R)-(3-Chlorophenyl)oxirane
(R)-(3-Chlorophenyl)oxirane
More 白箭头 黑箭头
(R)-(4-Fluorophenyl)oxirane
(R)-(4-Fluorophenyl)oxirane
(R)-(4-Fluorophenyl)oxirane
More 白箭头 黑箭头
(R)-1-(4-Bromophenyl)ethanol
(R)-1-(4-Bromophenyl)ethanol
(R)-1-(4-Bromophenyl)ethanol
More 白箭头 黑箭头
(R)-2-((4-Nitrophenethyl)amino)-1-phenylethanol Hydrochloride
(R)-2-((4-Nitrophenethyl)amino)-1-phenylethanol Hydrochloride
(R)-2-((4-Nitrophenethyl)amino)-1-phenylethanol Hydrochloride
More 白箭头 黑箭头
(R)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-4-benzylmorpholin-3-one
(R)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-4-benzylmorpholin-3-one
(R)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-4-benzylmorpholin-3-one
More 白箭头 黑箭头
(R)-2-(1-Hydroxyethyl)pyridine
(R)-2-(1-Hydroxyethyl)pyridine
(R)-2-(1-Hydroxyethyl)pyridine
More 白箭头 黑箭头
(R)-2-(4-Chlorophenyl)oxirane
(R)-2-(4-Chlorophenyl)oxirane
(R)-2-(4-Chlorophenyl)oxirane
More 白箭头 黑箭头
(R)-4-(1-Hydroxyethyl)pyridine
(R)-4-(1-Hydroxyethyl)pyridine
(R)-4-(1-Hydroxyethyl)pyridine
More 白箭头 黑箭头
(S)-(-)-1-(1-Naphthyl)ethanol
(S)-(-)-1-(1-Naphthyl)ethanol
(S)-(-)-1-(1-Naphthyl)ethanol
More 白箭头 黑箭头
(S)-(-)-1-Phenylethanol
(S)-(-)-1-Phenylethanol
(S)-(-)-1-Phenylethanol
【Alias】D-1-phenylethanol; (S)-(-)-1-phenylethanol
【Catalog Number】CR8010
【CAS #】1445-91-6
【Molecular Formula】C8H10O
【Molecular Weight】122.16
More 白箭头 黑箭头
(S)-(-)-Styrene Oxide
(S)-(-)-Styrene Oxide
(S)-(-)-Styrene Oxide
More 白箭头 黑箭头
(S)-1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile
(S)-1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile
(S)-1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile
More 白箭头 黑箭头
(S)-1-(4-Bromophenyl)ethanol
(S)-1-(4-Bromophenyl)ethanol
(S)-1-(4-Bromophenyl)ethanol
More 白箭头 黑箭头
Previous page
1
2
3

News Center

Viwit’s Levetiracetam Tablets Approved by FDA 2024-04-09 11:28:41
On April 5, 2024, Viwit Pharmaceuticals' Levetiracetam Tablets received an Approval Letter (#078869) from the U.S. Food and Drug Administration (FDA), marking Viwit's first approved oral solid dosage in the United States.
Viwit Pharmaceuticals' Mirabegron API Receives Official Approval by China NMPA 2024-01-26 11:09:29
On January 23, 2024, Viwit Pharmaceuticals received the "Notice of Approval of Application for Listing of Chemical APIs" issued by China National Medical Products Administration (NMPA) for its own proprietary active pharmaceutical ingredient (API) Mirabegron, developed independently. The issued registration number is Y20220000096, and the corresponding notice number is 2024YS00039.
Viwit Pharmaceuticals' Vildagliptin Tablets Receive Official Approval by China NMPA 2023-12-22 13:19:44
Viwit Pharmaceuticals is pleased to announce the acquisition of the Drug Registration Certificate (Certificate No: 2023S01974) from the National Medical Products Administration (NMPA) for a proprietary finished dosage form, Vildagliptin tablet. This signifies the official approval of this product in the Chinese market.
Viwit Pharmaceuticals' Lidocaine Injection Receives Official Approval by China NMPA 2023-12-19 11:25:05
On December 18, 2023, Viwit Pharmaceuticals received the "Drug Supplementary Application Approval Notice" (Notice No: 2023B06224) issued by the China National Medical Products Administration for a proprietary finished dosage form, Lidocaine Hydrochloride for Injection (5ml: 0.1g).
Viwit Pharmaceuticals' Vildagliptin API Receives Official Approval by China NMPA 2023-12-07 08:31:28
On November 30, 2023, Viwit Pharmaceuticals received the "Notice of Approval of Application for Listing of Chemical APIs" issued by National Medical Products Administration (NMPA) for its independently developed active pharmaceutical ingredient (API), Vildagliptin. The registration number is Y20210000619, and the notice number is 2023YS00803.
Viwit Pharmaceuticals' Aprepitant API Receives Official Approval by China NMPA 2023-10-31 15:33:57
On October 26, 2023, Viwit Pharmaceuticals received the "Notice of Approval of Application for Listing of Chemical APIs" issued by China National Medical Products Administration (NMPA) for the independently developed active pharmaceutical ingredient (API) Aprepitant. The registration number is Y20210000473, and the notice number is 2023YS00727.

(R)-(4-Fluorophenyl)oxirane

Product Name : (R)-(4-Fluorophenyl)oxirane
CAS# : 134356-73-3
产品描述
Parameters

 

Molecular Formula C8H7FO
Molecular Weight 138.14
Molecular Structure
Product Description Light yellow to yellow liquid;
Purity (by HPLC): ≥98.0%;
Chiral purity (by HPLC): ≥98.0%;
An intermediate for chiral drugs.
Packing Size Pack as per customer requirement
Storage Condition Airtight and store at cool place.
 
Scan the QR code to read on your phone
We could not find any corresponding parameters, please add them to the properties table
Previous
(R)-(+)-1-(1-Naphthyl)ethanol
Next
(R)-(3-Chlorophenyl)oxirane
search
Confirm
Close
About Us
Company Introduction Corporate History Business Introduction Corporate Governance Company Culture Corporate Honors Viwit Family Media Center Video
R&D and Innovation
R&D Innovation Product Pipeline Achievements
Products
Drug Products Biologics APIs Intermediates Boranes
Innovation
CDMO Project Collaboration In-/Out-Licensing Joint Venture
Sustainable
EHS Energy Quality Supplier
News Center
In 2024 In 2023 In 2022 In 2021 In 2020 In 2019 In 2018 In 2017 In 2016
Join Us
Talent Philosophy Talent Development Salary and Benefits Campus Recruiting Social Recruitment
Contact Us
Online Message Contact Us
News Center
dp EN
dp 中文

wz

wz